Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical tranexamic acid after percutaneous nephrolithotomy
IRCT20180625040232N2Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in Bleeding (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoints: Hemoglobin change, Hospital stay days and 1 more. Started Jan 2020; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Bleeding
Beyond the preview
Go deeper on IRCT20180625040232N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180625040232N2.